Top Rare Diseases Companies
5 Rare Diseases companies, sorted by total funding raised.
5
Companies
$448.5M
Combined Funding
Series B
Top Stage
Indexed tracks 5 Rare Diseases companies that have collectively raised $448.5M in documented funding. The most-funded rare diseases companies tracked include CANbridge and Reneo Pharmaceuticals. Series B is the most common funding stage among rare diseases companies in this dataset.
CANbridge is a biotechnology company focused on developing and commercializing rare disease thera...
Biopharmaceutical company licensing and developing drugs to treat fibrosis.
Biopharmaceutical company focused on developing treatments for rare diseases
Biotechnology company developing new medicines to treat rare disorders of calcification with init...
Developing a novel therapeutic for the rare disease Creatine Transporter Deficiency, an inborn er...
Frequently Asked Questions
How many Rare Diseases companies are tracked on Indexed?
Indexed tracks 5 Rare Diseases companies, sorted by total funding raised.
How much funding have Rare Diseases companies raised in total?
The Rare Diseases companies tracked by Indexed have collectively raised $448.5M in documented funding.
What are the top-funded Rare Diseases companies?
The most-funded Rare Diseases companies tracked include CANbridge, Reneo Pharmaceuticals, Clementia.
Explore More
Other Industries